West Pharmaceutical Services | WST - Operating Profit


West Pharmaceutical Services reported $-199.7M in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
Align Technology USD 193.04M 1.72M Sep/2026
Baxter International USD 314M 38M Sep/2026
Becton, Dickinson and Co. USD 1.11B 357M Sep/2026
Cerus USD -1.45M 488K Dec/2024
Charles River Laboratories USD 202.64M 82.75M Sep/2026
Cooper Companies USD 222M 253M Jun/2026
Dentsply International USD 38M 46M Sep/2026
Haemonetics USD 75.12M 17.66M Sep/2026
ICU Medical USD 58.59M 1.84M Sep/2026
Insulet USD 189.8M 60.1M Sep/2026
Integra LifeSciences USD 42.65M 1.36M Sep/2026
IQVIA Holdings USD 608M 1.99B Sep/2026
J&J USD 6.47B 1B Sep/2026
Medtronic USD 1.84B 254M Jun/2026
Merit Medical Systems USD 60.4M 16.25M Jun/2026
Neogen USD -1.8M 4.9M Jun/2026
OraSure Technologies USD -13.59M 2.13M Dec/2025
Quidel USD 12.1M 27.4M Sep/2026
Repligen USD 24.31M 3.18M Sep/2026
Rockwell Medical USD 515K 1.84M Jun/2024
Solventum Corp USD 68M 113M Sep/2026
STAAR Surgical USD 5.46M 4.64M Sep/2026
Terumo JPY 89.48B 58.03B Jun/2026
Utah Medical Products USD 2.56M 124K Mar/2026
West Pharmaceutical Services USD -199.7M 378.8M Sep/2026